NYSE:SOLV Solventum (SOLV) Stock Price, News & Analysis $88.76 +1.23 (+1.41%) Closing price 03:59 PM EasternExtended Trading$88.85 +0.09 (+0.10%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Solventum Stock (NYSE:SOLV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Solventum alerts:Sign Up Key Stats Today's Range$86.53▼$89.5350-Day Range$76.23▼$92.4452-Week Range$62.38▼$94.16Volume2.32 million shsAverage Volume1.35 million shsMarket Capitalization$15.11 billionP/E Ratio10.85Dividend YieldN/APrice Target$92.80Consensus RatingModerate Buy Company Overview Solventum Corporation (NYSE:SOLV) is a global healthcare company that develops products and technologies intended to improve patient care, support healthcare professionals and increase the efficiency of healthcare delivery. The company serves hospitals, clinics, dental practices, laboratories, government agencies and other healthcare-related organizations. Its offerings include medical and surgical products such as wound-care, skin-care, infection-prevention and surgical solutions; dental products and materials; and health information systems that support clinical documentation, coding, workflow and decision-making. Solventum also provides purification and filtration technologies used in healthcare, life sciences and other specialized applications. Solventum became an independent public company on April 1, 2024, following its separation from 3M. The company is headquartered in St. Paul, Minnesota, and operates across international markets. Bryan Hanson serves as Solventum’s president and chief executive officer.AI Generated. May Contain Errors. Read More Solventum Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks33rd Percentile Overall ScoreSOLV MarketRank™: Solventum scored higher than 33% of companies evaluated by MarketBeat, and ranked 716th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.6 / 5Analyst RatingModerate Buy Consensus RatingSolventum has received a consensus rating of Moderate Buy. The company's average rating score is 2.58, and is based on no strong buy ratings, 8 buy ratings, 3 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Solventum is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageSolventum has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Solventum's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth-0.83% Earnings GrowthEarnings for Solventum are expected to decrease by -0.83% in the coming year, from $7.23 to $7.17 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Solventum is 10.89, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.92.Price to Earnings Ratio vs. SectorThe P/E ratio of Solventum is 10.89, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.65.Price to Earnings Growth RatioSolventum has a PEG Ratio of 1.39. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSolventum has a P/B Ratio of 3.06. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Solventum's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted2.53% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 4.36.Change versus previous monthShort interest in Solventum has recently increased by 23.84%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSolventum does not currently pay a dividend.Dividend GrowthSolventum does not have a long track record of dividend growth. News and Social Media2.4 / 5News Sentiment0.78 News SentimentSolventum has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Solventum this week, compared to 5 articles on an average week.Search InterestOnly 4 people have searched for SOLV on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Solventum to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Solventum insiders have not sold or bought any company stock.Percentage Held by Insiders0.24% of the stock of Solventum is held by insiders.Percentage Held by InstitutionsSolventum has minimal institutional ownership at this time.Read more about Solventum's insider trading history. Receive SOLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SOLV Stock News HeadlinesSolventum: Divestiture Unlocking Upside In A Spinoff Revaluation PlaySeptember 18 at 8:00 AM | seekingalpha.comWhat Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For ShareholdersSeptember 17 at 9:00 AM | finance.yahoo.comThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this supercycle - and says that may be conservative. Billionaire Pierre Lassonde has argued for $19,000. Former CIA advisor Jim Rickards targets $27,000 based on a federal revaluation of the gold supply. But the bigger opportunity may not be gold itself. A 'backdoor' gold-linked asset has historically multiplied gold's move by 10x or more - returning 846%, 1,668%, 1,847%, and 1,915% in the last supercycle.September 18 at 1:00 AM | Traders Agency (Ad)Q2 surgical equipment & consumables - diversified earnings: Solventum (NYSE:SOLV) impressesSeptember 16 at 2:35 PM | msn.comBTIG Research Reiterates Buy Rating for Solventum (NYSE:SOLV)September 16 at 1:06 AM | americanbankingnews.comWhy Solventum (SOLV) is a top stock for the long termSeptember 15 at 1:32 PM | msn.comWall Street Zen Upgrades Solventum (NYSE:SOLV) to BuySeptember 12, 2026 | americanbankingnews.comSolventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeptember 9, 2026 | seekingalpha.comSee More Headlines SOLV Stock Analysis - Frequently Asked Questions How have SOLV shares performed this year? Solventum's stock was trading at $79.25 at the beginning of the year. Since then, SOLV stock has increased by 12.5% and is now trading at $89.1470. How were Solventum's earnings last quarter? Solventum Corporation (NYSE:SOLV) released its quarterly earnings data on Wednesday, August, 5th. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $1.91 by $0.64. The firm's revenue was up 2.2% compared to the same quarter last year. Read the conference call transcript. How will Solventum's stock buyback program work? Solventum's Board of Directors approved a stock buyback program on Thursday, November 20th 2025, which authorizes the company to repurchase $1,000,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 7.5% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's management believes its shares are undervalued. Who are Solventum's major shareholders? Top institutional shareholders of Solventum include Diamond Hill Capital Management LLC Investment Advisor (1.12%), Bank of New York Mellon Corp (0.46%), Lone Peak Global Investors LLC (0.25%) and Wedge Capital Management L L P NC (0.22%). View institutional ownership trends. How do I buy shares of Solventum? Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Solventum own? Based on aggregate information from My MarketBeat watchlists, some other companies that Solventum investors own include Chevron (CVX), American Water Works (AWK), The RMR Group (RMR), Bristol Myers Squibb (BMY), DiamondRock Hospitality (DRH), Waste Connections (WCN) and AUO (AUOTY). Company Calendar Last Earnings8/05/2026Today9/18/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 SOLV's financial health is in the Green zone, according to TradeSmith. SOLV has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Supplies Current SymbolNYSE:SOLV Previous SymbolNYSE:SOLV CIK1964738 Webwww.solventum.com Phone651-733-1110FaxN/AEmployees20,000Year Founded2023Price Target and Rating Average Price Target for Solventum$92.80 High Price Target$113.00 Low Price Target$60.00 Potential Upside/Downside+4.6%Consensus RatingModerate Buy Rating Score (0-4)2.58 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)$8.18 Trailing P/E Ratio10.85 Forward P/E Ratio12.28 P/E Growth1.39Net Income$1.56 billion Net Margins17.26% Pretax Margin20.41% Return on Equity25.09% Return on Assets8.78% Debt Debt-to-Equity Ratio1.00 Current Ratio1.02 Quick Ratio0.74 Sales & Book Value Annual Sales$8.33 billion Price / Sales1.81 Cash Flow$8.98 per share Price / Cash Flow9.88 Book Value$29.11 per share Price / Book3.05Miscellaneous Outstanding Shares170,220,000Free Float169,815,000Market Cap$15.11 billion OptionableOptionable Beta0.61 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NYSE:SOLV) was last updated on 9/18/2026 by MarketBeat.com Staff. From Our PartnersWhy This Small AI Company Holds 150 PatentsJeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...Brownstone Research | Sponsored$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | Sponsored$747 million in one quarter - with a 60% cash-flow targetThe company posted $747 million in net income last quarter and plans to return at least 60% of 2026 free cash ...Monument Traders Alliance | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredIran War WARNING: Something Just ChangedA powerful Middle Eastern government is reportedly asking Trump for U.S. military help against Iran backed for...Banyan Hill Publishing | SponsoredPorter flew 3,300 miles to investigate this systemPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SOLV Stock Alerts